RHHBY Related Mergers and Acquisitions
-
UPDATE: Shares of Life Technologies (LIFE) Spike, Potential Roche Bid
-
Roche Prepared to Pay $66/Share for Illumina (ILMN) - Reports
-
Illumina (ILMN) Shares Slammed as Roche (RHHBY) to Drop $51/Share Bid
-
Roche (RHHBY) Says $51/Share Bid for Illumina (ILMN) 'Full and Fair' Offer
-
Roche (RHHBY) Sends Letter to Illumina (ILMN) Holders; Says Illumina NOT the Apple of Genomics Biz
-
Illumina (ILMN) Gets Backing from ISS in Saying Roche (RHHBY) Offer is 'Inadequate'
-
Roche (RHHBY) 'Disappointed' that Illumina (ILMN) Rejected $51/Share Offer
-
UPDATE: Illumina (ILMN) Rejects $51/Share Roche (RHHBY) Bid
-
Roche (RHHBY) Sweetens Illumina (ILMN) Bid to $51/Share
-
Illumina (ILMN) Sends Letter to Shareholders Over Roche (RHHBY) Bid; Says Price 'Inadequate'
-
Roche (RHHBY) Extends $44.50/Sr. Offer for Illumina (ILMN) By Nearly One Month
-
llumina (ILMN) Sends Letter to Shareholders Over Roche (RHHBY) Offer
-
Roche (RHHBY) Needs to Give FTC Extra Information in Illumina (ILMN) Bid
-
Illumina (ILMN) Says Roche (RHHBY) Offer 'Does Not Reflect' Its Unique Position
-
Life Tech (LIFE) Could Be Juicy M&A Target Following Illumina (ILMN) Bid
-
Illumina (ILMN) CEO Flatley Thinks Board is 'Highly Qualified'
-
Roche (RHHBY) Commences $44.50/Share Tender for Illumina (ILMN)
-
Illumina (ILMN) Boad Will Review Roche's (RHHBY) Unsolicited Bid
-
Roche (RHHBY) Disappointed in Illumina (ILMN) Adopting Poison Pill
-
Illumina (ILMN) Adopts Poison Pill in Response to Roche (RHHBY) Bid
-
Investors, Analysts Consider Roche's Bid for Illumina (ILMN) Too Low
-
Auriga Reiterates a 'Buy' on Illumina (ILMN); Roche Goes Hostile - Likely Only An Opening Offer
-
Illumina (ILMN) to Review $44.50/Share Bid by Roche (RHHBY)
-
Arrowhead Research (ARWR) Acquuires RNA Assets from Roche (RHHBY)
-
Anadys Pharmaceuticals (ANDS) Acquired by Roche for $3.70/Share, 256% Premium
-
Roche (RHHBY) Acquires MAS POC IT Connectivity Assets
-
Roche (RHHBY) Obtains Worldwide Biomarker PI3K License from Qiagen (QGEN) for PCR Assay Development
-
Roche CFO Says Co. Commited to Genentech (DNA) Deal -Reuters
-
Roche (RHHBY) Is Preparing A New Offer For Genentech (DNA)
-
Roche (RHHBY) Purchases Shares of Memory Pharmaceuticals (MEMY) in Tender Offer
-
Roche (RHHBY) Offer $89 Per Share for Remaining Interest in Genentech (DNA)
-
Ventana Medical Systems (VMSI) Rejects Roche's Unsolicited Tender Offer
-
CuraGen (CGEN) Spikes After Merger Announcement
Back to RHHBY Stock Lookup
